Global PET Radiopharmaceuticals Market Research Report 2021-2027

  • receipt Report ID : 215178
  • calendar_today Published On: May, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare

The PET Radiopharmaceuticals market report offers in-dept analysis on the global market size, market share, market growth, sales analysis, regional analysis, market developments, opportunities, and forecasts that will help you in strategizing and expanding your business.

As per the most recent analysis conducted by our research team, the global PET Radiopharmaceuticals market size is projected to reach US$ XX million by 2027 from US $ XX million in 2020 at a CAGR of XX% during 2021-2027.

The report included detailed analysis on the PET Radiopharmaceuticals production capacity, its market share by manufacturers, growth rate, regional production capacity, ex-factory rate, and other important data points. The report also covers PET Radiopharmaceuticals consumption globally as well as thorough bifurcation into regional and country wise consumption.

The research team goes an additional mile to comprehensively cover other important aspects on PET Radiopharmaceuticals market such as the market dynamics, market segmentation, competition, growth prospects, and growth strategies. The buyers of this report will have access to exclusive data that covers market share by applications, manufacturers, regions, and countries. The document also covers market size by type, market competition by manufacturers, sales volume, growth rate, revenue, price and gross margins. Moreover, the authors of this report provide authentic calculations and estimations for global revenue and volume by type segments for PET Radiopharmaceuticals market covering the period 2016-2027.

This report includes the following key manufacturers. We can also add other companies of your choice and customize the report as per your requirements.

  • Cardinal Health Inc. (U.S.)
  • Mallinckrodt plc (Ireland)
  • GE Healthcare (U.K.)
  • Lantheus Medical Imaging, Inc. (U.S.)
  • Bayer AG (Germany)
  • Bracco Imaging S.p.A (Italy)
  • Eczacibasi-Monrol Nuclear Products (Turkey)
  • Nordion, Inc. (Canada)
  • Advanced Accelerator Applications S.A. (France)
  • IBA Molecular Imaging (Belgium)

Market Segment by Type

  • F-18
  • Ru-82
  • Others

Market Segment by Application

  • Oncology
  • Cardiology
  • Neurology
  • Others

Market Segment by Regions and Countries

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, India, Japan, Taiwan, South Korea, Australia, Indonesia, Singapore, Malaysia, Rest of Asia-Pacific)
  • Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
  • Central & South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Turkey, Rest of Middle East & Africa)

The study objectives of this report are:

  • Overview of the PET Radiopharmaceuticals market
  • Analysis on key market segments
  • Key manufacturer analysis based on production, sales, and revenue
  • PET Radiopharmaceuticals market regional and country wise analysis for production and consumption
  • Study the forecast of market in respect to manufacturers, segments, and regions
  • Identify significant trends and factors driving the market growth
  • Analyse the available opportunities in the market by tracing high growth segments
  • Analyse competitive developments like acquisitions, expansions, product launches, agreements, etc.
  • Study the growth strategies of key manufacturers
  • SWOT analysis

In this study, the years considered to estimate the market size of PET Radiopharmaceuticals are as follows:

History Year: 2016-2020

Base Year: 2020

Estimated Year: 2021

Forecast Year 2021 to 2027

Available Customizations

Market Research Place offers customizations according to the client's specific needs. The report can be customized on the basis of manufacturers, regions, applications, etc. Contact us to know more about the customization options.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type

1.2.2 F-18

1.2.3 Ru-82

1.2.4 Others

1.3 Market Segment by Application

1.3.1 Global PET Radiopharmaceuticals Market Share by Application (2016 VS 2021 VS 2027)

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Neurology

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global PET Radiopharmaceuticals Market Size (2016-2027)

2.1.1 Global PET Radiopharmaceuticals Revenue (2016-2027)

2.1.2 Global PET Radiopharmaceuticals Sales (2016-2027)

2.2 Global PET Radiopharmaceuticals Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027

2.2.1 Global PET Radiopharmaceuticals Sales by Regions (2016-2021)

2.2.2 Global PET Radiopharmaceuticals Revenue by Regions (2016-2021)

2.3 Global PET Radiopharmaceuticals Market Size Forecast by Region

2.3.1 Global PET Radiopharmaceuticals Sales Forecast by Region (2022-2027)

2.3.2 Global PET Radiopharmaceuticals Revenue Forecast by Region (2022-2027)

2.4 Global Top PET Radiopharmaceuticals Regions (Countries) Ranking by Market Size

2.5 PET Radiopharmaceuticals Industry Trends

2.5.1 PET Radiopharmaceuticals Market Trends

2.5.2 PET Radiopharmaceuticals Market Drivers

2.5.3 PET Radiopharmaceuticals Market Challenges

2.5.4 PET Radiopharmaceuticals Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top PET Radiopharmaceuticals Manufacturers by Sales (2016-2021)

3.1.1 Global PET Radiopharmaceuticals Sales by Manufacturers (2016-2021)

3.1.2 Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2016-2021)

3.1.3 Global 5 and 10 Largest Manufacturers by PET Radiopharmaceuticals Sales in 2020

3.2 Global Top Manufacturers PET Radiopharmaceuticals by Revenue

3.2.1 Global PET Radiopharmaceuticals Revenue by Manufacturers (2016-2021)

3.2.2 Top PET Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue

3.2.3 Global PET Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)

3.2.4 Global PET Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PET Radiopharmaceuticals as of 2020)

3.4 Global PET Radiopharmaceuticals Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers PET Radiopharmaceuticals Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into PET Radiopharmaceuticals Market

3.7 Key Manufacturers PET Radiopharmaceuticals Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global PET Radiopharmaceuticals Market Size by Type

4.1 Global PET Radiopharmaceuticals Historic Market Review by Type (2016-2021)

4.1.1 Global PET Radiopharmaceuticals Sales Market Share by Type (2016-2021)

4.1.2 Global PET Radiopharmaceuticals Revenue Market Share by Type (2016-2021)

4.1.3 PET Radiopharmaceuticals Price by Type (2016-2021)

4.2 Global PET Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)

4.2.1 Global PET Radiopharmaceuticals Sales Forecast by Type (2022-2027)

4.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Type (2022-2027)

4.2.3 PET Radiopharmaceuticals Price Forecast by Type (2022-2027)

5 Global PET Radiopharmaceuticals Market Size by Application

5.1 Global PET Radiopharmaceuticals Historic Market Review by Application (2016-2021)

5.1.1 Global PET Radiopharmaceuticals Sales Market Share by Application (2016-2021)

5.1.2 Global PET Radiopharmaceuticals Revenue Market Share by Application (2016-2021)

5.1.3 PET Radiopharmaceuticals Price by Application (2016-2021)

5.2 Global PET Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)

5.2.1 Global PET Radiopharmaceuticals Sales Forecast by Application (2022-2027)

5.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Application (2022-2027)

5.2.3 PET Radiopharmaceuticals Price Forecast by Application (2022-2027)

6 North America

6.1 North America PET Radiopharmaceuticals Sales Breakdown by Company

6.1.1 North America PET Radiopharmaceuticals Sales by Company (2016-2027)

6.1.2 North America PET Radiopharmaceuticals Revenue by Company (2016-2027)

6.2 North America PET Radiopharmaceuticals Market Size by Type (2016-2027)

6.2.1 North America PET Radiopharmaceuticals Sales by Type (2016-2027)

6.2.2 North America PET Radiopharmaceuticals Revenue by Type (2016-2027)

6.3 North America PET Radiopharmaceuticals Market Size by Application (2016-2027)

6.3.1 North America PET Radiopharmaceuticals Sales by Application (2016-2027)

6.3.2 North America PET Radiopharmaceuticals Revenue by Application (2016-2027)

6.4 North America PET Radiopharmaceuticals Market Size by Country

6.4.1 North America PET Radiopharmaceuticals Sales by Country (2016-2027)

6.4.2 North America PET Radiopharmaceuticals Revenue by Country (2016-2027)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe PET Radiopharmaceuticals Sales Breakdown by Company

7.1.1 Europe PET Radiopharmaceuticals Sales by Company (2016-2027)

7.1.2 Europe PET Radiopharmaceuticals Revenue by Company (2016-2027)

7.2 Europe PET Radiopharmaceuticals Market Size by Type (2016-2027)

7.2.1 Europe PET Radiopharmaceuticals Sales by Type (2016-2027)

7.2.2 Europe PET Radiopharmaceuticals Revenue by Type (2016-2027)

7.3 Europe PET Radiopharmaceuticals Market Size by Application (2016-2027)

7.3.1 Europe PET Radiopharmaceuticals Sales by Application (2016-2027)

7.3.2 Europe PET Radiopharmaceuticals Revenue by Application (2016-2027)

7.4 Europe PET Radiopharmaceuticals Market Size by Country

7.4.1 Europe PET Radiopharmaceuticals Sales by Country (2016-2027)

7.4.2 Europe PET Radiopharmaceuticals Revenue by Country (2016-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific PET Radiopharmaceuticals Sales Breakdown by Company

8.1.1 Asia Pacific PET Radiopharmaceuticals Sales by Company (2016-2027)

8.1.2 Asia Pacific PET Radiopharmaceuticals Revenue by Company (2016-2027)

8.2 Asia Pacific PET Radiopharmaceuticals Market Size by Type (2016-2027)

8.2.1 Asia Pacific PET Radiopharmaceuticals Sales by Type (2016-2027)

8.2.2 Asia Pacific PET Radiopharmaceuticals Revenue by Type (2016-2027)

8.3 Asia Pacific PET Radiopharmaceuticals Market Size by Application (2016-2027)

8.3.1 Asia Pacific PET Radiopharmaceuticals Sales by Application (2016-2027)

8.3.2 Asia Pacific PET Radiopharmaceuticals Revenue by Application (2016-2027)

8.4 Asia Pacific PET Radiopharmaceuticals Market Size by Regions

8.4.1 Asia Pacific PET Radiopharmaceuticals Sales by Regions

8.4.2 Asia Pacific PET Radiopharmaceuticals Revenue by Regions

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

8.4.12 Philippines

8.4.13 Vietnam

9 Latin America

9.1 Latin America PET Radiopharmaceuticals Sales Breakdown by Company

9.1.1 Latin America PET Radiopharmaceuticals Sales by Company (2016-2027)

9.1.2 Latin America PET Radiopharmaceuticals Revenue by Company (2016-2027)

9.2 Latin America PET Radiopharmaceuticals Market Size by Type (2016-2027)

9.2.1 Latin America PET Radiopharmaceuticals Sales by Type (2016-2027)

9.2.2 Latin America PET Radiopharmaceuticals Revenue by Type (2016-2027)

9.3 Latin America PET Radiopharmaceuticals Market Size by Application (2016-2027)

9.3.1 Latin America PET Radiopharmaceuticals Sales by Application (2016-2027)

9.3.2 Latin America PET Radiopharmaceuticals Revenue by Application (2016-2027)

9.4 Latin America PET Radiopharmaceuticals Market Size by Country

9.4.1 Latin America PET Radiopharmaceuticals Sales by Country (2016-2027)

9.4.2 Latin America PET Radiopharmaceuticals Revenue by Country (2016-2027)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa PET Radiopharmaceuticals Sales Breakdown by Company

10.1.1 Middle East and Africa PET Radiopharmaceuticals Sales by Company (2016-2027)

10.1.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Company (2016-2027)

10.2 Middle East and Africa PET Radiopharmaceuticals Market Size by Type (2016-2027)

10.2.1 Middle East and Africa PET Radiopharmaceuticals Sales by Type (2016-2027)

10.2.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Type (2016-2027)

10.3 Middle East and Africa PET Radiopharmaceuticals Market Size by Application (2016-2027)

10.3.1 Middle East and Africa PET Radiopharmaceuticals Sales by Application (2016-2027)

10.3.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Application (2016-2027)

10.4 Middle East and Africa PET Radiopharmaceuticals Market Size by Country

10.4.1 Middle East and Africa PET Radiopharmaceuticals Sales by Country (2016-2027)

10.4.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2016-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Company Profiles

11.1 Cardinal Health Inc. (U.S.)

11.1.1 Cardinal Health Inc. (U.S.) Corporation Information

11.1.2 Cardinal Health Inc. (U.S.) Overview

11.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Products and Services

11.1.5 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis

11.1.6 Cardinal Health Inc. (U.S.) Recent Developments

11.2 Mallinckrodt plc (Ireland)

11.2.1 Mallinckrodt plc (Ireland) Corporation Information

11.2.2 Mallinckrodt plc (Ireland) Overview

11.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Products and Services

11.2.5 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals SWOT Analysis

11.2.6 Mallinckrodt plc (Ireland) Recent Developments

11.3 GE Healthcare (U.K.)

11.3.1 GE Healthcare (U.K.) Corporation Information

11.3.2 GE Healthcare (U.K.) Overview

11.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Products and Services

11.3.5 GE Healthcare (U.K.) PET Radiopharmaceuticals SWOT Analysis

11.3.6 GE Healthcare (U.K.) Recent Developments

11.4 Lantheus Medical Imaging, Inc. (U.S.)

11.4.1 Lantheus Medical Imaging, Inc. (U.S.) Corporation Information

11.4.2 Lantheus Medical Imaging, Inc. (U.S.) Overview

11.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Products and Services

11.4.5 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis

11.4.6 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments

11.5 Bayer AG (Germany)

11.5.1 Bayer AG (Germany) Corporation Information

11.5.2 Bayer AG (Germany) Overview

11.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Products and Services

11.5.5 Bayer AG (Germany) PET Radiopharmaceuticals SWOT Analysis

11.5.6 Bayer AG (Germany) Recent Developments

11.6 Bracco Imaging S.p.A (Italy)

11.6.1 Bracco Imaging S.p.A (Italy) Corporation Information

11.6.2 Bracco Imaging S.p.A (Italy) Overview

11.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Products and Services

11.6.5 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals SWOT Analysis

11.6.6 Bracco Imaging S.p.A (Italy) Recent Developments

11.7 Eczacibasi-Monrol Nuclear Products (Turkey)

11.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information

11.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Overview

11.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Products and Services

11.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals SWOT Analysis

11.7.6 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments

11.8 Nordion, Inc. (Canada)

11.8.1 Nordion, Inc. (Canada) Corporation Information

11.8.2 Nordion, Inc. (Canada) Overview

11.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Products and Services

11.8.5 Nordion, Inc. (Canada) PET Radiopharmaceuticals SWOT Analysis

11.8.6 Nordion, Inc. (Canada) Recent Developments

11.9 Advanced Accelerator Applications S.A. (France)

11.9.1 Advanced Accelerator Applications S.A. (France) Corporation Information

11.9.2 Advanced Accelerator Applications S.A. (France) Overview

11.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Products and Services

11.9.5 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals SWOT Analysis

11.9.6 Advanced Accelerator Applications S.A. (France) Recent Developments

11.10 IBA Molecular Imaging (Belgium)

11.10.1 IBA Molecular Imaging (Belgium) Corporation Information

11.10.2 IBA Molecular Imaging (Belgium) Overview

11.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Products and Services

11.10.5 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals SWOT Analysis

11.10.6 IBA Molecular Imaging (Belgium) Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 PET Radiopharmaceuticals Value Chain Analysis

12.2 PET Radiopharmaceuticals Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 PET Radiopharmaceuticals Production Mode & Process

12.4 PET Radiopharmaceuticals Sales and Marketing

12.4.1 PET Radiopharmaceuticals Sales Channels

12.4.2 PET Radiopharmaceuticals Distributors

12.5 PET Radiopharmaceuticals Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

List of Tables

Table 1. Global PET Radiopharmaceuticals Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)

Table 2. Major Manufacturers of F-18

Table 3. Major Manufacturers of Ru-82

Table 4. Major Manufacturers of Others

Table 5. Global PET Radiopharmaceuticals Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)

Table 6. Global Market PET Radiopharmaceuticals Market Size (US$ Million) by Region: 2016 VS 2021 VS 2027

Table 7. Global PET Radiopharmaceuticals Sales by Region (2016-2021) & (K Pcs)

Table 8. Global PET Radiopharmaceuticals Sales Market Share by Region (2016-2021)

Table 9. Global PET Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)

Table 10. Global PET Radiopharmaceuticals Revenue Market Share by Region (2016-2021)

Table 11. Global PET Radiopharmaceuticals Sales Forecast by Region (2022-2027) & (K Pcs)

Table 12. Global PET Radiopharmaceuticals Sales Market Share Forecast by Region (2022-2027)

Table 13. Global PET Radiopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 14. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Region (2022-2027)

Table 15. Top PET Radiopharmaceuticals Regions (Countries) Ranking by Market Size (US$ Million) in 2020

Table 16. PET Radiopharmaceuticals Market Trends

Table 17. PET Radiopharmaceuticals Market Drivers

Table 18. PET Radiopharmaceuticals Market Challenges

Table 19. PET Radiopharmaceuticals Market Restraints

Table 20. Global PET Radiopharmaceuticals Sales by Manufacturers (2016-2021) & (K Pcs)

Table 21. Global PET Radiopharmaceuticals Sales Share by Manufacturers (2016-2021)

Table 22. Global PET Radiopharmaceuticals Revenue by Manufacturers (2016-2021) & (US$ Million)

Table 23. Ranking of Global Top PET Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2020

Table 24. PET Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)

Table 25. Global PET Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PET Radiopharmaceuticals as of 2020)

Table 27. Key Manufacturers PET Radiopharmaceuticals Average Selling Price (ASP) & (2016-2021) & (USD/Pcs)

Table 28. Key Manufacturers PET Radiopharmaceuticals Plants/Factories Distribution

Table 29. Key Manufacturers PET Radiopharmaceuticals Area Served

Table 30. Date of Key Manufacturers Enter into PET Radiopharmaceuticals Market

Table 31. Key Manufacturers PET Radiopharmaceuticals Product Type

Table 32. Mergers & Acquisitions, Expansion Plans

Table 33. Global PET Radiopharmaceuticals Sales (K Pcs) by Type (2016-2021)

Table 34. Global PET Radiopharmaceuticals Sales Share by Type (2016-2021)

Table 35. Global PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2016-2021)

Table 36. Global PET Radiopharmaceuticals Price (K Pcs) by Type (2016-2021)

Table 37. Global PET Radiopharmaceuticals Sales (K Pcs) by Type (2022-2027)

Table 38. Global PET Radiopharmaceuticals Sales Share by Type (2022-2027)

Table 39. Global PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2022-2027)

Table 40. Global PET Radiopharmaceuticals Revenue Share by Type (2022-2027)

Table 41. Global PET Radiopharmaceuticals Price (K Pcs) by Type (2022-2027)

Table 42. Global PET Radiopharmaceuticals Sales (K Pcs) by Application (2016-2021)

Table 43. Global PET Radiopharmaceuticals Sales Share by Application (2016-2021)

Table 44. Global PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2016-2021)

Table 45. Global PET Radiopharmaceuticals Price (K Pcs) by Application (2016-2021)

Table 46. Global PET Radiopharmaceuticals Sales (K Pcs) by Application (2022-2027)

Table 47. Global PET Radiopharmaceuticals Sales Share by Application (2022-2027)

Table 48. Global PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2022-2027)

Table 49. Global PET Radiopharmaceuticals Revenue Share by Application (2022-2027)

Table 50. Global PET Radiopharmaceuticals Price (K Pcs) by Application (2022-2027)

Table 51. North America PET Radiopharmaceuticals Sales by Company (2016-2021) & (K Pcs)

Table 52. North America PET Radiopharmaceuticals Sales Market Share by Company (2016-2021)

Table 53. North America PET Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)

Table 54. North America PET Radiopharmaceuticals Revenue Market Share by Company (2016-2021)

Table 55. North America PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)

Table 56. North America PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)

Table 57. North America PET Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)

Table 58. North America PET Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)

Table 59. North America PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)

Table 60. North America PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)

Table 61. North America PET Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)

Table 62. North America PET Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)

Table 63. North America PET Radiopharmaceuticals Sales by Country (2016-2021) & (K Pcs)

Table 64. North America PET Radiopharmaceuticals Sales by Country (2022-2027) & (K Pcs)

Table 65. North America PET Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)

Table 66. North America PET Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)

Table 67. Europe PET Radiopharmaceuticals Sales by Company (2016-2021) & (K Pcs)

Table 68. Europe PET Radiopharmaceuticals Sales Market Share by Company (2016-2021)

Table 69. Europe PET Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)

Table 70. Europe PET Radiopharmaceuticals Revenue Market Share by Company (2016-2021)

Table 71. Europe PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)

Table 72. Europe PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)

Table 73. Europe PET Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)

Table 74. Europe PET Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)

Table 75. Europe PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)

Table 76. Europe PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)

Table 77. Europe PET Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)

Table 78. Europe PET Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)

Table 79. Europe PET Radiopharmaceuticals Sales by Country (2016-2021) & (K Pcs)

Table 80. Europe PET Radiopharmaceuticals Sales by Country (2022-2027) & (K Pcs)

Table 81. Europe PET Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)

Table 82. Europe PET Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)

Table 83. Asia Pacific PET Radiopharmaceuticals Sales by Company (2016-2021) & (K Pcs)

Table 84. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Company (2016-2021)

Table 85. Asia Pacific PET Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)

Table 86. Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Company (2016-2021)

Table 87. Asia Pacific PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)

Table 88. Asia Pacific PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)

Table 89. Asia Pacific PET Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)

Table 90. Asia Pacific PET Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)

Table 91. Asia Pacific PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)

Table 92. Asia Pacific PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)

Table 93. Asia Pacific PET Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)

Table 94. Asia Pacific PET Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)

Table 95. Asia Pacific PET Radiopharmaceuticals Sales by Region (2016-2021) & (K Pcs)

Table 96. Asia Pacific PET Radiopharmaceuticals Sales by Region (2022-2027) & (K Pcs)

Table 97. Asia Pacific PET Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)

Table 98. Asia Pacific PET Radiopharmaceuticals Revenue by Region (2022-2027) & (US$ Million)

Table 99. Latin America PET Radiopharmaceuticals Sales by Company (2016-2021) & (K Pcs)

Table 100. Latin America PET Radiopharmaceuticals Sales Market Share by Company (2016-2021)

Table 101. Latin America PET Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)

Table 102. Latin America PET Radiopharmaceuticals Revenue Market Share by Company (2016-2021)

Table 103. Latin America PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)

Table 104. Latin America PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)

Table 105. Latin America PET Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)

Table 106. Latin America PET Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)

Table 107. Latin America PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)

Table 108. Latin America PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)

Table 109. Latin America PET Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)

Table 110. Latin America PET Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)

Table 111. Latin America PET Radiopharmaceuticals Sales by Country (2016-2021) & (K Pcs)

Table 112. Latin America PET Radiopharmaceuticals Sales by Country (2022-2027) & (K Pcs)

Table 113. Latin America PET Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)

Table 114. Latin America PET Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)

Table 115. Middle East and Africa PET Radiopharmaceuticals Sales by Company (2016-2021) & (K Pcs)

Table 116. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Company (2016-2021)

Table 117. Middle East and Africa PET Radiopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)

Table 118. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Company (2016-2021)

Table 119. Middle East and Africa PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)

Table 120. Middle East and Africa PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)

Table 121. Middle East and Africa PET Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)

Table 122. Middle East and Africa PET Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)

Table 123. Middle East and Africa PET Radiopharmaceuticals Sales by Application (2016-2021) & (K Pcs)

Table 124. Middle East and Africa PET Radiopharmaceuticals Sales by Application (2022-2027) & (K Pcs)

Table 125. Middle East and Africa PET Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)

Table 126. Middle East and Africa PET Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)

Table 127. Middle East and Africa PET Radiopharmaceuticals Sales by Country (2016-2021) & (K Pcs)

Table 128. Middle East and Africa PET Radiopharmaceuticals Sales by Country (2022-2027) & (K Pcs)

Table 129. Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)

Table 130. Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)

Table 131. Cardinal Health Inc. (U.S.) Corporation Information

Table 132. Cardinal Health Inc. (U.S.) Description and Overview

Table 133. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 134. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product and Services

Table 135. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis

Table 136. Cardinal Health Inc. (U.S.) Recent Developments

Table 137. Mallinckrodt plc (Ireland) Corporation Information

Table 138. Mallinckrodt plc (Ireland) Description and Overview

Table 139. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 140. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product and Services

Table 141. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals SWOT Analysis

Table 142. Mallinckrodt plc (Ireland) Recent Developments

Table 143. GE Healthcare (U.K.) Corporation Information

Table 144. GE Healthcare (U.K.) Description and Overview

Table 145. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 146. GE Healthcare (U.K.) PET Radiopharmaceuticals Product and Services

Table 147. GE Healthcare (U.K.) PET Radiopharmaceuticals SWOT Analysis

Table 148. GE Healthcare (U.K.) Recent Developments

Table 149. Lantheus Medical Imaging, Inc. (U.S.) Corporation Information

Table 150. Lantheus Medical Imaging, Inc. (U.S.) Description and Overview

Table 151. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 152. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product and Services

Table 153. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis

Table 154. Lantheus Medical Imaging, Inc. (U.S.) Recent Developments

Table 155. Bayer AG (Germany) Corporation Information

Table 156. Bayer AG (Germany) Description and Overview

Table 157. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 158. Bayer AG (Germany) PET Radiopharmaceuticals Product and Services

Table 159. Bayer AG (Germany) PET Radiopharmaceuticals SWOT Analysis

Table 160. Bayer AG (Germany) Recent Developments

Table 161. Bracco Imaging S.p.A (Italy) Corporation Information

Table 162. Bracco Imaging S.p.A (Italy) Description and Overview

Table 163. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 164. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product and Services

Table 165. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals SWOT Analysis

Table 166. Bracco Imaging S.p.A (Italy) Recent Developments

Table 167. Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information

Table 168. Eczacibasi-Monrol Nuclear Products (Turkey) Description and Overview

Table 169. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 170. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product and Services

Table 171. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals SWOT Analysis

Table 172. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments

Table 173. Nordion, Inc. (Canada) Corporation Information

Table 174. Nordion, Inc. (Canada) Description and Overview

Table 175. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 176. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product and Services

Table 177. Nordion, Inc. (Canada) PET Radiopharmaceuticals SWOT Analysis

Table 178. Nordion, Inc. (Canada) Recent Developments

Table 179. Advanced Accelerator Applications S.A. (France) Corporation Information

Table 180. Advanced Accelerator Applications S.A. (France) Description and Overview

Table 181. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 182. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product and Services

Table 183. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals SWOT Analysis

Table 184. Advanced Accelerator Applications S.A. (France) Recent Developments

Table 185. IBA Molecular Imaging (Belgium) Corporation Information

Table 186. IBA Molecular Imaging (Belgium) Description and Overview

Table 187. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 188. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product and Services

Table 189. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals SWOT Analysis

Table 190. IBA Molecular Imaging (Belgium) Recent Developments

Table 191. Key Raw Materials Lists

Table 192. Raw Materials Key Suppliers Lists

Table 193. PET Radiopharmaceuticals Distributors List

Table 194. PET Radiopharmaceuticals Customers List

Table 195. Research Programs/Design for This Report

Table 196. Key Data Information from Secondary Sources

Table 197. Key Data Information from Primary Sources

List of Figures

Figure 1. PET Radiopharmaceuticals Product Picture

Figure 2. Global PET Radiopharmaceuticals Sales Market Share by Type in 2020 & 2027

Figure 3. F-18 Picture

Figure 4. Ru-82 Picture

Figure 5. Others Picture

Figure 6. Global PET Radiopharmaceuticals Sales Market Share by Application in 2020 & 2027

Figure 7. Oncology Use Case

Figure 8. Cardiology Use Case

Figure 9. Neurology Use Case

Figure 10. Others Use Case

Figure 11. PET Radiopharmaceuticals Report Years Considered

Figure 12. Global PET Radiopharmaceuticals Revenue, (US$ Million), 2016 VS 2021 VS 2027

Figure 13. Global PET Radiopharmaceuticals Market Size 2016-2027 (US$ Million)

Figure 14. Global PET Radiopharmaceuticals Sales (2016-2021) & (K Pcs)

Figure 15. Global PET Radiopharmaceuticals Market Size Market Share by Region: 2020 VS 2027

Figure 16. Global PET Radiopharmaceuticals Sales Market Share by Region (2016-2021)

Figure 17. Global PET Radiopharmaceuticals Sales Market Share by Region in 2020

Figure 18. Global PET Radiopharmaceuticals Revenue Market Share by Region in 2016 VS 2020

Figure 19. Global PET Radiopharmaceuticals Sales Share by Manufacturers In 2020

Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by PET Radiopharmaceuticals Sales in 2020

Figure 21. PET Radiopharmaceuticals Revenue Share by Manufacturers In 2020

Figure 22. PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

Figure 23. Global PET Radiopharmaceuticals Revenue Share by Type (2016-2021)

Figure 24. Global PET Radiopharmaceuticals Revenue Growth Rate by Type in 2016 & 2020

Figure 25. Global PET Radiopharmaceuticals Revenue Share by Application (2016-2021)

Figure 26. Global PET Radiopharmaceuticals Revenue Growth Rate by Application in 2016 & 2020

Figure 27. North America PET Radiopharmaceuticals Sales Market Share by Type (2016-2027)

Figure 28. North America PET Radiopharmaceuticals Revenue Market Share by Type (2016-2027)

Figure 29. North America PET Radiopharmaceuticals Sales Market Share by Application (2016-2027)

Figure 30. North America PET Radiopharmaceuticals Revenue Market Share by Application (2016-2027)

Figure 31. North America PET Radiopharmaceuticals Sales Share by Country (2016-2027)

Figure 32. North America PET Radiopharmaceuticals Revenue Share by Country (2016-2027)

Figure 33. U.S. PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 34. Canada PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 35. Europe PET Radiopharmaceuticals Sales Market Share by Type (2016-2027)

Figure 36. Europe PET Radiopharmaceuticals Revenue Market Share by Type (2016-2027)

Figure 37. Europe PET Radiopharmaceuticals Sales Market Share by Application (2016-2027)

Figure 38. Europe PET Radiopharmaceuticals Revenue Market Share by Application (2016-2027)

Figure 39. Europe PET Radiopharmaceuticals Sales Share by Country (2016-2027)

Figure 40. Europe PET Radiopharmaceuticals Revenue Share by Country (2016-2027)

Figure 41. Germany PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 42. France PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 43. U.K. PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 44. Italy PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 45. Russia PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 46. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Type (2016-2027)

Figure 47. Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Type (2016-2027)

Figure 48. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Application (2016-2027)

Figure 49. Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Application (2016-2027)

Figure 50. Asia Pacific PET Radiopharmaceuticals Sales Share by Region (2016-2027)

Figure 51. Asia Pacific PET Radiopharmaceuticals Revenue Share by Region (2016-2027)

Figure 52. China PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 53. Japan PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 54. South Korea PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 55. India PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 56. Australia PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 57. Taiwan PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 58. Indonesia PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 59. Thailand PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 60. Malaysia PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 61. Philippines PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 62. Vietnam PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 63. Latin America PET Radiopharmaceuticals Sales Market Share by Type (2016-2027)

Figure 64. Latin America PET Radiopharmaceuticals Revenue Market Share by Type (2016-2027)

Figure 65. Latin America PET Radiopharmaceuticals Sales Market Share by Application (2016-2027)

Figure 66. Latin America PET Radiopharmaceuticals Revenue Market Share by Application (2016-2027)

Figure 67. Latin America PET Radiopharmaceuticals Sales Share by Country (2016-2027)

Figure 68. Latin America PET Radiopharmaceuticals Revenue Share by Country (2016-2027)

Figure 69. Mexico PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 70. Brazil PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 71. Argentina PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 72. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Type (2016-2027)

Figure 73. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Type (2016-2027)

Figure 74. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Application (2016-2027)

Figure 75. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Application (2016-2027)

Figure 76. Middle East and Africa PET Radiopharmaceuticals Sales Share by Country (2016-2027)

Figure 77. Middle East and Africa PET Radiopharmaceuticals Revenue Share by Country (2016-2027)

Figure 78. Turkey PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 79. Saudi Arabia PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 80. UAE PET Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)

Figure 81. PET Radiopharmaceuticals Value Chain

Figure 82. PET Radiopharmaceuticals Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

Please fill the form below, to recieve the report sample


+1